Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients

Fig. 6

Correlation analysis of the BCRFS-related CAF signature with various clinical characteristics of patients with prostate cancer based on GSE116918 and TCGA datasets. A Correlation analysis of risk score with gleason grade. B Correlation analysis of risk score with PSA. C Correlation analysis of risk score with clinical T stage and pathologic T stage. CAF: cancer-associated fibroblast; BCRFS: biochemical recurrence-free survival; PSA: prostate specific antigen

Back to article page